A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)
Clinical trial NCT00644709 · COMPLETED
Trial details
- NCT number
- NCT00644709
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.